ES2190730A1 - Systemic nasal congestion pharmaceutical consists of an ingestible sulfate, gum and glycerine based mixture with additives - Google Patents
Systemic nasal congestion pharmaceutical consists of an ingestible sulfate, gum and glycerine based mixture with additivesInfo
- Publication number
- ES2190730A1 ES2190730A1 ES200101346A ES200101346A ES2190730A1 ES 2190730 A1 ES2190730 A1 ES 2190730A1 ES 200101346 A ES200101346 A ES 200101346A ES 200101346 A ES200101346 A ES 200101346A ES 2190730 A1 ES2190730 A1 ES 2190730A1
- Authority
- ES
- Spain
- Prior art keywords
- nasal congestion
- systemic
- gum
- pharmaceutical
- ingestible
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Landscapes
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Abstract
Pharmaceutical compound for systemic treatment of nasal congestion.Compound for treating nasal congestion that consists of incorporating pseudoephedrine sulphate into a chewable pharmaceutical form through which, during its ingestions, the nose is decongested in a systemic manner it incorporates as base rubber, xylitol, manitol, glycerine, maltitol syrup, acesulphame K, aspartame, pseudoephedrine sulphate, sorbitol and aromas.The systemic nasal congestion pharmaceutical comprises an ingestible product incorporating pseudo ephedrine sulfate. The product also contains base gum, xylitol, manitol, glycerine, acesulpham K, aspartam, aromas, sorbitol, and maltitol syrup.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
ES200101346A ES2190730B1 (en) | 2001-06-11 | 2001-06-11 | PHARMACEUTICAL COMPOSITION TO TREAT NASAL CONGESTION VIA SYSTEMS. |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
ES200101346A ES2190730B1 (en) | 2001-06-11 | 2001-06-11 | PHARMACEUTICAL COMPOSITION TO TREAT NASAL CONGESTION VIA SYSTEMS. |
Publications (2)
Publication Number | Publication Date |
---|---|
ES2190730A1 true ES2190730A1 (en) | 2003-08-01 |
ES2190730B1 ES2190730B1 (en) | 2004-12-01 |
Family
ID=27675887
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
ES200101346A Expired - Fee Related ES2190730B1 (en) | 2001-06-11 | 2001-06-11 | PHARMACEUTICAL COMPOSITION TO TREAT NASAL CONGESTION VIA SYSTEMS. |
Country Status (1)
Country | Link |
---|---|
ES (1) | ES2190730B1 (en) |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP3389629B1 (en) * | 2015-12-17 | 2021-04-21 | Urgo Recherche Innovation et Développement | Liquid composition for use as a nasal solution |
Citations (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4800083A (en) * | 1986-10-20 | 1989-01-24 | R. P. Scherer Corporation | Sustained release method and product |
US5560921A (en) * | 1992-06-01 | 1996-10-01 | The Procter & Gamble Company | Chewable decongestant compositions |
US5681577A (en) * | 1993-06-04 | 1997-10-28 | Warner-Lambert Company | Multiple action cold/sinus preparations |
WO2000023046A1 (en) * | 1998-10-16 | 2000-04-27 | Bush Boake Allen Inc. | Chewable or dissolvable pharmaceutical compositions suitable for oral administration |
WO2000056281A1 (en) * | 1999-03-22 | 2000-09-28 | Atp Avant-Garde Technologies & Product Marketing & Licensing S.A. | Composition for medicated chewing gums, process for manufacturing the same and tablets so obtained |
-
2001
- 2001-06-11 ES ES200101346A patent/ES2190730B1/en not_active Expired - Fee Related
Patent Citations (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4800083A (en) * | 1986-10-20 | 1989-01-24 | R. P. Scherer Corporation | Sustained release method and product |
US5560921A (en) * | 1992-06-01 | 1996-10-01 | The Procter & Gamble Company | Chewable decongestant compositions |
US5681577A (en) * | 1993-06-04 | 1997-10-28 | Warner-Lambert Company | Multiple action cold/sinus preparations |
WO2000023046A1 (en) * | 1998-10-16 | 2000-04-27 | Bush Boake Allen Inc. | Chewable or dissolvable pharmaceutical compositions suitable for oral administration |
WO2000056281A1 (en) * | 1999-03-22 | 2000-09-28 | Atp Avant-Garde Technologies & Product Marketing & Licensing S.A. | Composition for medicated chewing gums, process for manufacturing the same and tablets so obtained |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP3389629B1 (en) * | 2015-12-17 | 2021-04-21 | Urgo Recherche Innovation et Développement | Liquid composition for use as a nasal solution |
Also Published As
Publication number | Publication date |
---|---|
ES2190730B1 (en) | 2004-12-01 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
KR100511730B1 (en) | Compositions having improved delivery of actives | |
AU770376B2 (en) | Compositions having improved stability | |
US20060073189A1 (en) | Chewing gums, lozenges, candies, tablets, liquids, and sprays for efficient delivery of medications and dietary supplements | |
WO2004069198A3 (en) | Sugar-free oral transmucosal solid dosage forms and uses thereof | |
WO2005020906A3 (en) | Intranasal opioid compositions | |
NO20030915L (en) | Method of anesthesia | |
WO2003045331A3 (en) | Formulations for oral administration of cromolyn sodium | |
WO2005065318A3 (en) | Effervescent oral opiate dosage form | |
WO2006100075A8 (en) | Use of an artificial sweetener to enhance absorption of nicotine | |
PE20020694A1 (en) | ORAL COMPOSITIONS THAT HAVE IMPROVED AESTHETIC CHARACTERISTICS OF THE CONSUMER | |
ATE374601T1 (en) | MULTIPARTICULAR MEDICINAL FORM, CONTAINING MUCOADHAESIVELY FORMULATED PEPTIDE OR PROTEIN ACTIVE INGREDIENTS, AND A METHOD FOR PRODUCING THE MEDICINAL FORM | |
BR0308927A (en) | Pleasant Chewable Tablet | |
GB2367005A (en) | Pharmaceutical formulations and methods comprising intranasal morphine | |
ECSP066385A (en) | MULTIVITAMIN SYRUP FOR CHILDREN OR YOUNG ADULTS | |
MXPA05013270A (en) | Transmucosal form of administration with reduced mucosal irritation. | |
ES2190730A1 (en) | Systemic nasal congestion pharmaceutical consists of an ingestible sulfate, gum and glycerine based mixture with additives | |
EP1694295B1 (en) | Pharmaceutical oral dosage form comprising a non-steroidal anti-inflammatory drug, and having good palatability | |
KR20010101476A (en) | Compositions having improved stability | |
WO2003077846A3 (en) | New therapeutic method of delivering a medicament to avoid irritating effects on membranes of user | |
EP3087982A1 (en) | Flavored analgesic and decongestant spray | |
GB2412865A (en) | Cough mixture comprising ipecacuanha and guaifenesin | |
MXPA01007020A (en) | Compositions having improved stability | |
MXPA01007015A (en) | Compositions having improved delivery of actives |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
EC2A | Search report published |
Date of ref document: 20030801 Kind code of ref document: A1 |
|
FG2A | Definitive protection |
Ref document number: 2190730B1 Country of ref document: ES |
|
FD2A | Announcement of lapse in spain |
Effective date: 20180928 |